Here, we show that BAG5, a BAG domain-containing family member, interacts with both Hsp70 and parkin with deleterious functional consequences. Through these interactions, BAG5 inhibits Hsp70 chaperone activity and parkin E3 ubiquitin ligase activity and enhances the sequestration of parkin within LB-like protein aggregates. In contrast, short hairpin-mediated depression of BAG5 expression decreases the sequestration of parkin within protein aggregates. Furthermore, BAG5 also mitigates parkin-mediated preservation of proteasome function and inhibition of cell death. Finally, we show that targeted expression of BAG5 in an in vivo model of PD enhances dopaminergic neurodegeneration, whereas a mutant form of BAG5 that can inhibit BAG5 function results in enhanced cell survival. number XM_127149) ( Figure 1A) .
Results

BAG5 Expression Is Induced in Dopaminergic
Using species-specific probes directed against the open reading frame of BAG5, we identified two transcripts of BAG5 that were widely and differentially ex-pressed in multiple tissue types, including rat and human brain ( Figure 1B) . In situ hybridization (ISH) analysis in rat brain using an antisense cRNA probe directed against rat BAG5 revealed BAG5 expression in cortex, hippocampus, red nucleus, and the SNpc ( Figure 1C,  upper panel) . A control sense cRNA probe did not reveal any structure-specific signal above background ( Figure  1C, lower panel) . ISH with digoxygenin (DIG)-labeled antisense rat BAG5 probes combined with immunohistochemistry (IHC) for tyrosine hydroxylase (TH), a marker for dopaminergic neurons, demonstrated that BAG5 mRNA was expressed in the dopaminergic neurons of the SNpc ( Figure 1D ). We also verified the increase in BAG5 expression in these neurons at 24 hr following MFB axotomy both qualitatively ( Figure 1D To test this, we performed in vitro GST pull-down assays Molecular weight markers are shown in kDa.
(PDAs) using recombinant fusion proteins. We found that GST-BAG5, like GST-BAG1, pulled the ATPase domain of Hsp70 is both necessary and sufficient for the interaction between BAG5 and Hsp70. down full-length Hsp70 in vitro, whereas GST-alone did not ( Figure 3A) . To identify the region of Hsp70 that To further confirm the specificity of the interaction between BAG5 and Hsp70, we aligned its BAG domains mediates the interaction with BAG5, we generated His- . However, BAG5 significantly inhibited the ability of Hsp70 to prevent aggregation, gregates was specific to parkin, we transfected cells with GFP alone and found that less than 1% of cells whereas cotransfection of the mutant BAG5(DARA) did not ( Figure 5C ). Given that the mutant BAG5(DARA) incontained any detectable inclusions ( Figure 5C ).
The solubility of parkin and its mutants within a cell hibited the effect of BAG5 on Hsp70 ( Figure 3G ), we tested whether the coexpression of BAG5(DARA) could can be enhanced by the coexpression of the chaperones Hsp70 and Hsp40 with parkin (Winklhofer et al., 2003) .
also mitigate BAG5 inhibition of Hsp70-mediated sup-pression of parkin sequestration. Indeed, we found a HEK293T cells, we observed a significant accumulation and aggregation of GFPu relative to those cells cotranssignificant decrease in the number of GFP-parkin-containing protein aggregates when BAG5 was cotransfected with empty vector (Figures 6A and 6B ). To ensure similar transfection efficiency between conditions, we fected with BAG5(DARA) ( Figure 5D ). The expression levels of GFP-parkin were similar in all conditions tested.
used DsRed and ␤-galactosidase as transfection controls. Taken together, our results suggest that the accuTaken together, these data suggest that BAG5, through its inhibition of Hsp70, can promote parkin sequestration mulation of synphilin alone is sufficient to induce proteasome inhibition as measured by the accumulation of and enhance the formation of LB-like protein aggregates.
GFPu some inhibitor lactacystin results in increased cell death, To confirm that our observed knockdown effect was which can be suppressed by parkin ( Figure 6E , left due to the specific depression of BAG5, we performed panel). The protective effect of parkin was significantly functional rescue experiments with rtBAG5, which is highly reduced by coexpression of BAG5 ( Figure 6E , left panel), homologous to huBAG5 but resistant to U6_shRNA_b5-while the coexpression of BAG5 alone with synphilin mediated knockdown ( Figure 5E ). Since BAG5 may proand ␣-synuclein expression in the presence of lactacysmote parkin sequestration through its inhibition of tin did not significantly enhance cell death ( Figure 6E,  Hsp70 (Figure 5C ), we first examined if rtBAG5 also right panel). To further validate our results, we used our mitigated Hsp70-mediated inhibition of parkin sequesU6_shRNA_b5 construct to depress the expression of tration in protein aggregates. Indeed, coexpression of BAG5 and found a significant decrease in cell death, rtBAG5 with Hsp70 and parkin prevented Hsp70-mediwhereas expression of a U6_shRNA_control construct ated inhibition of parkin sequestration. Significantly, had no effect ( Figure 6E , middle panel). The specificity rtBAG5 was able to functionally rescue the loss of huof this effect was demonstrated with functional rescue BAG5 inhibition of Hsp70 function in the presence of by coexpressing rat BAG5 with the U6_shRNA_b5 conU6_shRNA_b5 ( Figure 5G ). Taken together, these data struct. Finally, the mutant BAG5(DARA) was found to confirm that BAG5 has a functional role in the sequestrasuppress both the inhibitory effect of BAG5 on parkin tion of parkin in protein aggregates.
( Figure 6E , left panel) and when expressed alone ( Figure  6E , right panel). Figure 7E ), which we have shown to bind relative to control in animals receiving Ad.GFP ( Figures  7C and 7D) . Loss of dopaminergic neurons was verified to and mitigate the inhibitory effects of BAG5 on Hsp70 and parkin function ( Figures 3E-3G, 5D , and 6D-6E). We by cresyl violet staining to rule out the possibility that TH protein expression was downregulated postaxotomy found that targeted expression of BAG5(DARA) resulted in a significant increase in dopaminergic neuronal sur-(data not shown).
BAG5 Inhibits Parkin-Mediated Suppression of UPS Dysfunction and Cell Death
We next examined the effect of targeted expression vival ( Figures 7F and 7G) . Therefore, we conclude that targeted expression of BAG5 in the SNpc enhances doof BAG5 and the inhibitory mutant BAG5(DARA) in the SNpc in the well-defined 1-methyl-4-phenyl-1,2,3,6 -tetpaminergic neurodegeneration, whereas targeted ex- 
